Helmut BUSCHMANN,Oliver SZOLAR,Andrea WOLKERSTORFER,Norbert HANDLER,Franz-Ferdinand ROCH,Stephen CUSACK,Robert WEIKERT,Werner NEIDHART,Tanja SCHULZ-GASCH
申请号：
US15266224
公开号：
US20170081331A1
申请日:
2016.09.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a compound having the general formula (IIa) or (IIb), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
